Progression of sarcopenia among patients with pancreatic ductal adenocarcinoma receiving neoadjuvant therapy and the impact of pancreatic enzyme replacement therapy

Hepatobiliary & Pancreatic Diseases International · Elsevier

The publisher did not provide an abstract — full text is available via the link below.

Read at publisher →

Similar articles